Us Pfizer Doses
- All
- News
- Videos
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
US Authorizes Pfizer COVID-19 Booster Shot For Children As Young As 12
US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study
People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
-
Pfizer Vaccine Prevents Severe Covid For At Least 6 Months, Shows Study
Vaccination with two doses of the Pfizer jab stays highly effective against severe Covid -- including the Delta variant -- for at least six months, an analysis of US patients said Monday.
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
-
As US Health Body Debates Booster Dose, Spotlight On Israeli Study
A third dose of the Pfizer Inc.-BioNTech SE Covid vaccine can dramatically reduce rates of Covid-related illness in people 60 and older, according to data from a short-term study in Israel.
-
80% Covid Immunity Lost In 6 Months In Some After Pfizer Jab: US Study
COVID-19 antibodies produced by the Pfizer vaccine decreased more than 80 per cent in senior nursing home residents and their caregivers six months after receiving their second dose, a US study has found.
-
US To Donate 500 Million Pfizer Covid Vaccine Doses To 100 Poor Nations
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer coronavirus vaccine to some of the world's poorest countries, it said on Thursday, urging other G7 nations to follow suit.
-
US To Buy 500 Million Pfizer Vaccine Doses, Donate Jabs Globally: Report
The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.
-
"Pfizer, Moderna Won't Sell Shots To Us. They Said...": Arvind Kejriwal
Delhi Chief Minister Arvind Kejriwal today said Pfizer and Moderna have "refused to sell vaccines" to the state government. "They've told us they will talk to the central government," Mr Kejriwal said.
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
US Authorizes Pfizer COVID-19 Booster Shot For Children As Young As 12
US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study
People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
-
Pfizer Vaccine Prevents Severe Covid For At Least 6 Months, Shows Study
Vaccination with two doses of the Pfizer jab stays highly effective against severe Covid -- including the Delta variant -- for at least six months, an analysis of US patients said Monday.
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
-
As US Health Body Debates Booster Dose, Spotlight On Israeli Study
A third dose of the Pfizer Inc.-BioNTech SE Covid vaccine can dramatically reduce rates of Covid-related illness in people 60 and older, according to data from a short-term study in Israel.
-
80% Covid Immunity Lost In 6 Months In Some After Pfizer Jab: US Study
COVID-19 antibodies produced by the Pfizer vaccine decreased more than 80 per cent in senior nursing home residents and their caregivers six months after receiving their second dose, a US study has found.
-
US To Donate 500 Million Pfizer Covid Vaccine Doses To 100 Poor Nations
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer coronavirus vaccine to some of the world's poorest countries, it said on Thursday, urging other G7 nations to follow suit.
-
US To Buy 500 Million Pfizer Vaccine Doses, Donate Jabs Globally: Report
The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.
-
"Pfizer, Moderna Won't Sell Shots To Us. They Said...": Arvind Kejriwal
Delhi Chief Minister Arvind Kejriwal today said Pfizer and Moderna have "refused to sell vaccines" to the state government. "They've told us they will talk to the central government," Mr Kejriwal said.
